PT  - JOURNAL ARTICLE
AU  - Ware, Lisa J
AU  - Maposa, Innocent
AU  - Kolkenbeck-Ruh, Andrea
AU  - Norris, Shane
AU  - Soepnel, Larske
AU  - Crouch, Simone
AU  - Kagura, Juliana
AU  - Naidoo, Sanushka
AU  - Smith, Wayne
AU  - Davies, Justine
TI  - Heritability of cardiovascular health across three generations in South Africa: the Birth to Twenty-Plus cohort
AID  - 10.1101/2022.03.18.22272642
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.18.22272642
4099  - http://medrxiv.org/content/early/2022/03/21/2022.03.18.22272642.short
4100  - http://medrxiv.org/content/early/2022/03/21/2022.03.18.22272642.full
AB  - Objectives Cardiovascular disease is increasing in many low-middle income countries, including those in Africa. To inform strategies for the prevention of cardiovascular disease in South Africa, we sought to determine the broad heritability of phenotypic markers of cardiovascular risk across three generations.Design A cross-sectional study conducted in a longitudinal family cohort.Setting Research unit within a tertiary hospital in a historically disadvantaged, large urban township of South Africa.Participants 195 individuals from 65 biological families with all three generations including third generation children aged 4-10 years were recruited from the longest running intergenerational cohort study in Africa, the Birth to Twenty Plus cohort. All adults (grandparents and parents) were female, while children were male or female.Primary and secondary outcome measures The primary outcome was heritability of blood pressure (BP, brachial and central pressures). Secondary outcomes were heritability of arterial stiffness (pulse wave velocity), carotid intima media thickness (cIMT), and left ventricular mass indexed to body surface area (LVMI).Results While no significant intergenerational relationships of BP or arterial stiffness were found, there were significant relationships in LVMI across all three generations (p<0.04), and in cIMT between grandparents and parents (p=0.0166). Heritability estimates were 23-44% for cIMT and 21-39% for LVMI.Conclusions Structural indicators of vascular health, which are strong markers of future clinical cardiovascular outcomes transmit between generations within African families. Identification of these markers in parents may be useful to trigger assessments of preventable risk factors for cardiovascular disease in offspring.StrengthsIntergenerational transmission was evaluated for a range of indicators of cardiovascular health within urban African familiesThe sample included biological family members from three generationsHeritability estimates were compared for three commonly used statistical methods.LimitationsThe sample size is a limitation with the random family statistical method used to increase the numbers of comparisons available.Only maternal family members were included.Competing Interest StatementCompeting Interests: JD is a member of the Trial Steering Committee for D-Clare (UK MRC funded study: MR/T023562/1) for which no payment is received. She is also a member of the DSMB for NIH funded study (5R01HL144708) for which an honoraria of $200 is received. She has received the standard $400 NIH honoraria for being a panel member of their Implementation Science Grant funding stream and is a member of the WHO working group to discern targets for the Diabetes Compact. No other competing interests are declared.Funding StatementFunding statement: This work was supported by the Wellcome Trust (UK) grant number [214082/Z/18/Z].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Human Research Ethics Committee (Medical) of the University of the Witwatersrand approved the protocol (Ref: M190263).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors